Abstract
Polymyositis (PM) affects female gender during reproductive age; however, there is no study assessing ovarian reserve in these patients to evaluate ovarian reserve markers in PM. Eight female patients with PM (Bohan and Peter criteria, 1975) with aged 18–40 years, followed at our tertiary centre from March 2011 to May 2014, were invited to participate. They were age-matched with 16 healthy individuals (control group). All were evaluated at early follicular phase of menstrual cycle. Follicle stimulating hormone (FSH), estradiol, inhibin B, anti-Müllerian hormone (AMH) serum levels (ELISA) and sonographic antral follicle count (AFC) were determined. PM patients and controls had comparable mean age (31.4 ± 6.5 vs. 30.7 ± 6.2 years, P = 0.946), ethnicity and socioeconomic class (P > 0.05). PM mean age of onset was 27.3 ± 6.5 years and disease duration of 6.5 ± 4.1 years. Menstrual cycles were alike in both groups with a similar frequency of age at menarche, gynaecological age, duration and length of menstrual cycle (P > 0.05). The median serum level of AMH was significantly lower in PM compared to controls [0.7(0.3–3.4) vs. 3.1(1.4–4.0), P = 0.021]. AMH levels ≤1 ng/mL (50 vs. 6.3 %, P = 0.024) and very low AFC (37.5 vs. 6.3 %, P = 0.037) were significantly in PM patients versus controls. The other hormones (FSH, inhibin B and estradiol levels) were similar between both groups (P > 0.05). The present study was the first to identify subclinical ovarian dysfunction in PM patients during reproductive ages. Further study is necessary to assess the possible role of PM-related factors that may influence the ovarian function of these patients.
Similar content being viewed by others
References
Feldman BM, Rider LG, Reed AM, Pachman LM (2008) Juvenile dermatomyositis and other idiopathic inflammatory myopathies of childhood. Lancet 371:2201–2212
Greenver SA (2008) Inflammatory myopathies: evaluation and management. Semin Neurol 28:241–249
Ghaleb RM, Fahmy KA (2013) Anti-Müllerian hormone: a marker for ovarian function in systemic lupus erythematosus patients treated with cyclophosphamide. Joint Bone Spine 80:434–435
Appenzeller S, Blatyta PF, Costallat LTL (2008) Ovarian failure in SLE patients using pulse cyclophosphamide: comparison of different regimes. Rheumatol Int 28:567–571
Aikawa NE, Sallum AM, Leal MM, Bonfá E, Pereira RM, Silva CA (2010) Menstrual and hormonal alterations in juvenile dermatomyositis. Clin Exp Rheumatol 28:571–575
Souza FHC, Shinjo SK, Yamamaki LYS et al (2015) Reduction of ovarian reserve in adult patients with dermatomyositis. Clin Exp Rheumatol 33:44–49
Fanchin R, Schonäuer LM, Righini C, Guibourdenche J, Frydman R, Taieb J (2003) Serum anti-Müllerian hormone is more strongly related to ovarian follicular status than serum inhibin B, estradiol, FSH and LY on day 3. Hum Reprod 18:323–327
Bohan A, Peter JB (1975) Polymyositis and dermatomyositis (first of two parts). N Engl J Med 292:344–347
Almeida PM, Wickerhauser W (1991) Critério de classe econômica da associação brasileira de anunciantes (ABA) e associação brasileira dos institutos de pesquisa de mercado (ABIPEME). In: Almeida PM, Wickerhauser W (eds). O Critério ABA/ABIPEME, ABIPEME (São Paulo): 1–29
Legg AT, Merril JB (1932) Physical therapy in infantile paralysis. In: Principles and practice of physical therapy. Mock Pemberton and Coulter, Hagerstown
Bruce B, Fries JF (2003) The Stanford Health Assessment Questionnaire: dimensions and practical applications. Health Qual Life Outcomes 1:20
Hendriks DJ, Mol BW, Bancsi LF, Te Velde ER, Broekmans FJ (2005) Antral follicle count in the prediction of poor ovarian response and pregnancy after in vitro fertilization: a meta-analysis and comparison with basal follicle-stimulating hormone level. Fertil Steril 83:291–301
Jayaprakasan K, Campbell B, Hopkisson J, Johnson I, Raine-Fenning N (2010) A prospective, comparative analysis of anti-Müllerian hormone, inhibin B, and three-dimensional ultrasound determinants of ovarian reserve in the prediction of poor response to controlled ovarian stimulation. Fertil Steril 93:855–864
Köninger A, Koch L, Enekwe A, Birdir C, Kasimir-Bauer S, Kimiig R, Strowitzki T, Schmidt B (2015) Change of anti-Müllerian hormone levels during follicular phase in PCOS patients. Gynecol Endocrinol 31:26–33
Kerr GS, Hallahan CW, Giordano J et al (1994) Takayasu arteritis. Ann Intern Med 120:919–929
Silva CA, Brunner HI (2007) Gonadal functioning and preservation of reproductive fitness with juvenile systemic lupus erythematosus. Lupus 16:593–599
Silva CA, Bonfá E, Ostensen M (2010) Maintenance of fertility in patients with rheumatic diseases needing anti-inflammatory and immunosuppressive drugs. Arthritis Care Res 62:1682–1690
Satwik R, Kochhar M, Gupta SM, Majumdar A (2012) Anti-Müllerian hormone cut-off values for predicting poor ovarian response to exogenous ovarian stimulation in in-vitro fertilization. J Hum Reprod Sci 5:206–212
Kallio S, Purunen J, Ruokonen A et al (2013) Anti-Müllerian hormone levels decrease in women using combined contraception independently of administration route. Fertil Steril 99:1305–1310
Clark CA, Laskin CA, Cadesky K (2014) Anti-Mullerian hormone: reality check. Hum Reprod 29:184–185
Silva CA, Leal MM, Leone C et al (2002) Gonadal function in adolescents and young women with juvenile systemic lupus erythematosus. Lupus 11:419–425
Aikawa NE, Sallum AM, Pereira RM et al (2012) Subclinical impairment of ovarian reserve in juvenile systemic lupus erythematosus after cyclophosphamide therapy. Clin Exp Rheumatol 30:445–449
Araujo D, Yamakami L, Aikawa N et al (2014) Ovarian reserve in adult patients with childhood-onset lupus: a possible deleterious effect of methotrexate? Scand J Rheumatol 43:503–511
Lukaszuk K, Kuczynski W, Kunicki M et al (2014) Comparison of the second-generation Beckman Coulter IVD and first-generation AnshLabs ELISA assays for anti-Müllerian hormone in patients undergoing IVF treatment. Ginekol Pol 85:778–783
Mont’Alverne AR, Pereira RM, Yamakami LY et al (2014) Reduced ovarian reserve in patients with Takayasu arteritis. J Rheumatol 41:2055–2059
Mont’Alverne AR, Yamakami LY, Gonçalves CR, Baracat EC, Bonfá E, Silva CA (2015) Diminished ovarian reserve in Behçet’s disease patients. Clin Rheumatol 34:179–183
Yamakami LYS, Serafini PC, de Araujo DB et al (2014) Ovarian reserve in women with primary antiphospholipid syndrome. Lupus 23:862–867
Acknowledgments
We thank Elaine Pires Leon for technical support. This work was supported by Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP) [2011/15609-5 to S.K.S. and 2011/12471-2 to C.A.S.]; Federico Foundation to E.B., C.A.S. and S.K.S.; Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq) [305068/2014-8 to E.B. and 302724/2011-7 to C.A.S.] and by Núcleo de Apoio à Pesquisa “Saúde da Criança e do Adolescente” da USP (NAP-CriAd-SP) to C.A.S.
Disclosures
None.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
de Souza, F.H.C., da Silva, C.A., Yamakami, L.Y.S. et al. Reduced ovarian reserve in patients with adult polymyositis. Clin Rheumatol 34, 1795–1799 (2015). https://doi.org/10.1007/s10067-015-3064-1
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10067-015-3064-1